Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells

Ophthalmic Research

Volumn 43, Issue 3, 2010, Pages 139-144

  Matsuo, Sachiyo ^a   Ohguro, Hiroshi ^a   Ohguro, Ikuyo ^a   Nakazawa, Mitsuru ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Anticancer drug; Cancer associated retinopathy; Paraneoplastic syndrome; Recoverin

Indexed keywords

ACLARUBICIN; ALKALOID; DOKITAKISEL; DOXORUBICIN; GEMCITABINE; IRINOTECAN; MITOMYCIN C; RECOVERIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TISSUE MICROARRAY; TUMOR IMMUNITY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RECOVERIN; TRANSFECTION;

EID: 70350534289     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253486     Document Type: Article

References (52)

1. Jacobson DM, Thirkill CE, Tipping SJ: A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990; 28: 162-167.
2. Ohguro H, Nakazawa M: Pathological roles of Rec in cancer-associated retinopathy. Adv Exp Med Biol 2002; 514: 109-124.
3. Polans AS, Burton MD, Harley TL, Crabb JW, Palczewski K: Rec, but not visinin, is an autoantigen in human retina identified with a cancer associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 81-90.
4. Polans AP, Bucczlko J, Crabb J, Palczewsk K: A photoreceptor calcium-binding protein is recognized by autoantibodies obtained from patients with cancer associated retinopathy. J Cell Biol 1991; 112: 981-989.
5. Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JN: The cancer associated retinopathy antigen is a Rec-like protein. Invest Ophthalmol Vis Sci 1992; 3: 2768-2772.
6. Ohguro H, Ogawa K, Nakagawa T: Rec and Hsc70 are found as autoantigens with cancer- associated retinopathy. Invest Ophthalmol Vis Sci 1999; 40: 82-89.
7. Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M: Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 2004; 137: 1117-1119.
8. Kawamura S: Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin. Nature 1991; 362: 855-857.
9. Maeda T, Maeda A, Maruyama I, Ogawa K, Kuroki Y, Sawada H, Sato N, Ohguro H: Mechanisms of photoreceptor cell death in cancer associated retinopathy. Invest Ophthalmol Vis Sci 2001; 42: 705-712.
10. Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA: Role of anti-Rec autoantibodies in cancer associated retinopathy. Invest Ophthalmol Vis Sci 1993; 4: 2626-2633.
11. Matsubara S, Yamaji Y, Sato M, Fujita J, Takahara J: Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines. Br J Cancer 1996; 74: 1419-1422.
12. Yamaji Y, Matsubara S, Yamadori I, Sato M, Fujita T, Fujita J, Takahara J: Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy. Int J Cancer 1996; 65: 671-676.
13. Maeda A, Ohguro H, Maeda T, Wada I, Sato N, Kuroki Y: Aberrant expression of photoreceptor specific calcium binding protein (Rec) in cancer cell lines. Cancer Res 2000; 60: 1914-1920.
14. Ohguro H, Odagiri H, Miyagawa Y, Ohguro I, Sasaki M, Nakazawa M: Clinicopathological features of gastric cancer cases and aberrantly expressed recoverin. Tohoku J Exp Med 2004; 202: 213-219.
15. Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Hiroeki S, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N: Identification of human anti-tumor cytotoxic T-lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur J Immunol 2001; 31: 563-572.
16. Darnell RB, Deangelis LM: Regression of small cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 34: 21-22.
17. Miyagawa Y, Ohguro H, Odagiri H, Maruyama I, Maeda T, Maeda A, Sasaki M, Nakazawa M: Aberrantly expressed Rec is functionally associated with G-coupled receptor kinases in cancer cells. Biochem Biophys Res Commun 2003; 300: 669-673.
18. Lavie Y, Fiucci M, Liscovitch M: Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 1998; 273: 32380-32383.
19. Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP: Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 1998; 439: 368-372.
20. Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage- dependent cell growth. Cell 1998; 94: 625-634.
21. Schneider BJ, Kalemkerian GP: Chemotherapy for recurrent or refractory advanced non-small cell lung cancer; in Pass HI, Carbone DP, Minna JD, Johnson DH, Turrisi AT (eds): Lung Cancer: Principles and Practice, ed 3. Philadelphia, Lippincott Williams and Wilkins, pp 588-599.
22. Pitcher JA, Freedman NJ, Lefkowitz RJ: G protein-coupled receptor kinases. Annu Rev Biochem 1998; 67: 653-692.
23. Rothenberg KG, Heuser JE, Donzell WC, et al: Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68: 673-682.
24. Galbiati F, Volonte D, Gil O, et al: Expression of caveolin 1 and 2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is upregulated in response to cell injury. Proc Natl Acad Sci USA 1998; 95: 10257-10262.
25. Schnitzer JE, Oh P, Pinney E, Allard J: Filpin- sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of selected macromolecules. J Cell Biol 1994; 127: 1217-1232.
26. Schnitzer JE: Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001; 49: 265-280.
27. Parat MO, Anand-Apte B, Fox PL: Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 2003; 14: 3153-3168.
28. Carman CV, Lisanti MP, Benovic JL: Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 1999; 274: 8858-8864.
29. Michelle IL, Jun Y, Murata T, William CS: Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis and growth. Cancer Res 2007; 67: 2849-2856.
30. Lavie Y, Liscovitch M: Changes in lipid and protein constitutions of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconj J 2000; 17: 253-259.
31. Selleri S, Arnaboldi F, Palazzo M, Hussein U, Balsari A, Rumio C: Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy. Br J Dermatol 2005; 153: 506-513.
32. Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP: Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 1998; 439: 368-372.
33. Thirkill C, Keltner J, Tyler N, Roth A: Antibody reactions with retina and cancer-associated antigens in 10 patients with cancerassociated retinopathy. Arch Ophthalmol 1993; 111: 931-937.
34. Polans AS, Witkowska D, Haley TL: Rec, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92: 9176-9180.
35. Boucher MC, Allaire GS: Cancer-associated retinopathy: a clinicopathological case report. Can J Ophthalmol 1997; 32: 46-49.
36. Imaizumi M, Nakatsuka K, Matsumoto CS, Yatsuka Y: A case of cancer-associated retinopathy. Folia Ophthalmol Jpn 1998; 49: 381-385.
37. Kashiwabara K, Nakamura H, Kishi K, Yagyu H, Sarashina G, Kobayashi K, Matsuoka T: Cancer-associated retinopathy during treatment for small cell lung carcinoma. Intern Med 1999; 38: 597-601.
38. Msaoka N, Emoto Y, Sasaoka A: Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina 1999; 19: 462-464.
39. Kobayashi M, Ikezoe T, Uemura Y, Ueno H, Taguchi H: Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. Lung Cancer 2007; 57: 399-403.
40. Bazhin AV, Shifrina ON, Savchenko MS, Tikhomirova NK, Goncharskaia MA, Gorbunova VA, Senin II, Chuchalin AG, Philippov PP: Low titer autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Lung Cancer 2001; 34: 99-104.
41. Salgia R, Hedges TR, Rizk M: Cancer-associated retinopathy in a patient with non-small cell lung carcinoma. Lung Cancer 1998; 22: 149-152.
42. Savchenko MS, Bazhin AV, Shifrina ON, Demoura SA, Kogan EA, Chuchalin AG, Philippov PP: Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. Lung Cancer 2003; 41: 363-367.
43. Morita D, Matsukura S, Nakagawa Y, Kawai K: Cancer-associated retinopathy in a case of large-cell carcinoma of the lung. Jpn J Clin Ophthalmol 2006; 60: 1467-1470.
44. Ohashi H, Takahashi Y, Matsukura S, Kawai K: A patient of thymoma with cancer-associated retinopathy. Jpn J Clin Ophthalmol 2005; 59: 479-483.
45. Katsuta H, Okada M, Nakauchi T, Takahashi Y, Yamao S, Uchida S: Cancer-associated retinopathy associated with invasive thymoma. Am J Ophthalmol 2002; 134: 383-389.
46. Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E: Carcinoma-associated retinopathy: a review with clinical examples. Klin Monatsbl Augenheilkd 2000; 216: 17-24.
47. Chang PY, Tang CH, Yang CMP: Cancer-associated retinopathy in a patient with hepatocellular carcinoma. Case report and literature review. Retina 2005; 25: 1093-1096.
48. Eltabbakh GH, Hoogerland DL, Kay MC: Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol 1995; 58: 120-123.
49. Guy J, Aptsiauri N: Treatment of paraneoplactic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 1999; 117: 471-477.
50. Harmon JP, Purvin VA, Guy J: Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol 1999; 73: 430-432.
51. Matus G, Dicato M, Focan C: Cancer associated retinopathy (CAR). Two clinical cases and review of the literature. Rev Med Liege 2007; 62: 166-169.
52. Adamus G, Amundson D, MacKay C, Gouras P: Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol 1998; 116: 251-253.